Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Ambu A/S: Capital increase in connection with exercise of warrants issued
By: Nasdaq / GlobeNewswire - 22 Nov 2017Back to overview list

In December 2013, Ambu A/S issued 400,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 2.50. These warrants were issued to 52 employees with a vesting period of three years and may therefore be exercised in the trading window which was opened 9 November 2017 in connection with Ambu's Annual Report 2016/17.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via GlobeNewswire

HUG#2151378
Related companies:Ambu
Copyright 2017 Nasdaq / GlobeNewswire Back to overview list
to the top ↑